Massive Screening for Colorectal Cancer

Petrelli, Nicholas J.; Palmer, Michael L.; Michalek, Arthur M.; Herrera, Lemuel; Mink, Irving B.; Bersani, Gayle; Cummings, K. Michael

doi:10.1001/archsurg.1990.01410200113018

Cited by 9 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Variables which are difficult to control include: I) the compliance of a population to each strategy; 2) the availability of strategies; 3) the sensitivity of each method in a given center; 4) the need for additional tests should one test be inconclusive; and 5) the variability of costs between centers. Table 3 demonstrates the variability in estimates of cost per colorectal cancer found in three screening programs [35][36][37].…”

Section: Frequency Of Screeningmentioning

confidence: 99%

Cost‐effective management of colon and rectal cancer

Heine

Rothenberger

1991

World j. surg.

View full text Add to dashboard Cite

Health care costs in the United States of America continue to rise. Legislators, economists and third party payers are becoming increasingly concerned with intervention outcomes and the distribution of resources. It is the responsibility of the medical profession to assume a leading role in assessing the cost-effectiveness of health care interventions. Although many physicians perform informal cost-effectiveness analyses on a daily basis, health economists employ a variety of more complex methodologies. This article will attempt to provide physicians with an understanding of the value and limitations of the tools used in formal cost-effectiveness analyses and demonstrate how these tools may be applied to the management of colon and rectal cancer.

show abstract

Section: Frequency Of Screeningmentioning

confidence: 99%

Cost‐effective management of colon and rectal cancer

Heine

Rothenberger

1991

World j. surg.

View full text Add to dashboard Cite

show abstract

Fecal occult blood screening for colorectal cancer

Dam

Bond²,

Sivak³

1995

Archives of Internal Medicine

View full text Add to dashboard Cite

We critically analyzed the current literature on fecal occult blood testing as it pertains to colorectal cancer screening. We used articles published or referenced in the major English-language medical and gastroenterology journals for the last 10 years. Large, randomized controlled trials, case-control and cohort studies, and other sources containing information pertinent to the application of fecal occult blood testing for colorectal cancer screening were selected. Although the fecal occult blood test results are capable of predicting the presence of colorectal cancers and polyps, the sensitivity is variable in different studies and low for the latter. Nevertheless, most reports of its use emphasize that a relatively high percentage of the cancers detected are early-stage lesions. Currently available methods for colorectal cancer screening are imperfect, thereby increasing the cost-effectiveness ratio. The fecal occult blood test remains a workable approach to reducing the mortality from colorectal cancer provided it is carried out with attention to important variables such as the need for compliance, including the compliance of physicians.

show abstract

Perspectives in colorectal cancer

et al. 1991

View full text Add to dashboard Cite

This paper presents an overview of recent developments pertaining to colorectal adenocarcinoma. It is aimed toward the practicing clinician. Topics discussed include epidemiologic observations; genetic predispositions; molecular biology findings; screening and early detection programs; endoscopy; principles of surgical resection; laser and radioimmunoguided surgery; staging; selection of patients for adjuvant chemotherapy; and considerations regarding biologic response modifiers and pain control in the advanced-disease setting.

show abstract

Massive Screening for Colorectal Cancer

Cited by 9 publications

References 13 publications

Cost‐effective management of colon and rectal cancer

Cost‐effective management of colon and rectal cancer

Fecal occult blood screening for colorectal cancer

Perspectives in colorectal cancer

Contact Info

Product

Resources

About